PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹15,284 Cr | ₹14,925 Cr | ₹14,437 Cr | ₹12,717 Cr | ₹10,756 Cr |
What is the latest Total Liabilities ratio of PIRAMAL PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹15,284 Cr |
| Mar2024 | ₹14,925 Cr |
| Mar2023 | ₹14,437 Cr |
| Mar2022 | ₹12,717 Cr |
| Mar2021 | ₹10,756 Cr |
How is Total Liabilities of PIRAMAL PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹15,284 Cr | 2.41 | |
| Mar2024 | ₹14,925 Cr | 3.39 | |
| Mar2023 | ₹14,437 Cr | 13.52 | |
| Mar2022 | ₹12,717 Cr | 18.23 | |
| Mar2021 | ₹10,756 Cr | - | |
Compare Total Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹20,502.9 Cr | -0.6% | -11.5% | -37.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -0.6% |
-11.5% |
-37.1% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses